Ryan Fischesser - Dec 20, 2021 Form 4 Insider Report for Caribou Biosciences, Inc. (CRBU)

Signature
/s/ Barbara G. McClung as, attorney-in-fact
Stock symbol
CRBU
Transactions as of
Dec 20, 2021
Transactions value $
$3,056
Form type
4
Date filed
12/21/2021, 04:23 PM
Previous filing
Oct 12, 2021
Next filing
Jan 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRBU Common Stock Purchase $3.06K +1.14K +1.13% $2.69 102K Dec 20, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRBU Option to purchase Common Stock Exercise of in-the-money or at-the-money derivative security $0 -1.14K -13.33% $0.00 7.38K Dec 20, 2021 Common Stock 1.14K $2.69 Direct F2, F3
transaction CRBU Option to purchase Common Stock Award $0 +40K $0.00 40K Dec 20, 2021 Common Stock 40K $15.16 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired pursuant to the exercise of a stock option, as reported in Table II below.
F2 The exercise price for this stock option was incorrectly reported as $2.68 per share on the reporting person's Form 3 filed on July 23, 2021.
F3 The shares subject to this option have vested or will vest in equal monthly installments until the option is fully vested on January 1, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.
F4 The shares subject to this option will vest in equal monthly installments starting on the first monthly anniversary of the grant date until the option is fully vested on December 20, 2025, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.